Advances in the management of pleural disease

References

• Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 66(8), 663–668 (2011)
   PubMed Web of Science ®Google Scholar
• Farjah F , Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J. Thorac. Cardiovasc. Surg. 133(2), 346–351 (2007)
   PubMed Web of Science ®Google Scholar
• Byington CL, Hulten KG, Ampofo K et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J. Clin. Microbiol. 48(2), 520–525 (2010)
   PubMedGoogle Scholar
• Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 125(1), 26–33 (2010)
   PubMedGoogle Scholar
• Burgos J, Lujan M, Falco V et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin. Infect. Dis. 53(3), 254–261 (2011)
   PubMed Web of Science ®Google Scholar
• Koshy E , Murray J, Bottle A, Sharland M, Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997–2008. Thorax 65(9), 770–774 (2010)
   PubMed Web of Science ®Google Scholar
• Davies HE, Davies RJ, Davies CW; BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 (Suppl. 2), ii41–ii53 (2010)
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Abrahamson E, Cohen G et al. Paediatric Pleural Diseases Sub-Committee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 60 (Suppl. 1), i1–i21 (2005)
   Google Scholar
• Colice GL, Curtis A, Deslauriers J et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118(4), 1158–1171 (2000)
   PubMed Web of Science ®Google Scholar
• Sonnappa S, Cohen G, Owens CM et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am. J. Respir. Crit. Care Med. 174(2), 221–227 (2006)
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, West A et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N. Med. 365(6), 518–526 (2011)
   PubMed Web of Science ®Google Scholar
• Maskell NA, Davies CW, Nunn AJ et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N. Med. 352(9), 865–874 (2005)
   PubMed Web of Science ®Google Scholar
• Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am. J. Respir. Crit. Care Med. 160(5 Pt 1), 1682–1687 (1999)
   PubMedGoogle Scholar
• Desai G, Amadi W. Three years' experience of empyema thoracis in association with HIV infection. Trop. Doct. 31(2), 106–107 (2001)
   PubMedGoogle Scholar
• Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am. J. Respir. Crit. Care Med. 174(7), 817–823 (2006)
   PubMed Web of Science ®Google Scholar
• Meyer CN, Rosenlund S, Nielsen J, Friis-Møller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand. J. Infect. Dis. 43(3), 165–169 (2011)
   PubMed Web of Science ®Google Scholar
• Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am. J. Respir. Crit. Care Med. 151(6), 1700–1708 (1995)
   PubMed Web of Science ®Google Scholar
• Marks DJ, Fisk MD, Koo CY et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS ONE 7(1), e30074 (2012)
   PubMed Web of Science ®Google Scholar
• Langley JM, Kellner JD, Solomon N et al. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect. Dis. 8, 129 (2008)
   PubMedGoogle Scholar
• Menzies SM, Rahman NM, Wrightson JM et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 66(8), 658–662 (2011)
   PubMed Web of Science ®Google Scholar
• Insa R, Marín M, Martín A et al. Systematic use of universal 16S rRNA gene polymerase chain reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques. Medicine (Baltimore) 91(2), 103–110 (2012)
   PubMed Web of Science ®Google Scholar
• Light RW. Parapneumonic effusions and empyema. In: Pleural Diseases (5th edition). Lippincott, Williams and Wilkins, MD, USA, 179–210 (2007)
   Google Scholar
• Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J. Clin. Invest. 28(1), 173–190 (1949)
   Web of Science ®Google Scholar
• Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am. J. Respir. Crit. Care Med. 159(1), 37–42 (1999)
   PubMed Web of Science ®Google Scholar
• Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am. J. Respir. Crit. Care Med. 170(1), 49–53 (2004)
   PubMed Web of Science ®Google Scholar
• Thomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 57(4), 343–347 (2002)
   PubMed Web of Science ®Google Scholar
• Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst. Rev. (2), CD002312 (2004)
   Google Scholar
• Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 117(6), 1728–1733 (2000)
   PubMed Web of Science ®Google Scholar
• Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 178(1), 13–18 (2000)
   PubMed Web of Science ®Google Scholar
• Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med 106(5), 716–23 (2012)
   PubMedGoogle Scholar
• Zhu Z, Hawthorne ML, Guo Y et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 129(6), 1577–1583 (2006)
   PubMed Web of Science ®Google Scholar
• Brutsche MH, Tassi GF, Györik S et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest 128(5), 3303–3309 (2005)
   PubMed Web of Science ®Google Scholar
• Ravaglia C, Gurioli C, Tomassetti S et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema? Respiration 84(3), 219–224 (2012)
   PubMed Web of Science ®Google Scholar
• Suchar AM, Zureikat AH, Glynn L, Statter MB, Lee J, Liu DC. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema? Am. Surg. 72(8), 688–692 (2006)
   PubMed Web of Science ®Google Scholar
• Pappalardo E, Laungani A, Demarche M, Erpicum P. Early thoracoscopy for the management of empyema in children. Acta. Chir. Belg. 109(5), 602–605 (2009)
   PubMed Web of Science ®Google Scholar
• Mongardon N, Pinton-Gonnet C, Szekely B, Michel-Cherqui M, Dreyfus JF, Fischler M. Assessment of chronic pain after thoracotomy: a 1-year prevalence study. Clin. J. Pain 27(8), 677–681 (2011)
   PubMed Web of Science ®Google Scholar
• St Peter SD, Tsao K, Spilde TL et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 44(1), 106–111 (2009)
   PubMedGoogle Scholar
• Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 111(6), 1548–1551 (1997)
   PubMedGoogle Scholar
• Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J. Surg. 76(3), 120–122 (2006)
   PubMedGoogle Scholar
• Chambers A, Routledge T, Dunning J, Scarci M. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema? Interact. Cardiovasc. Thorac. Surg. 11(2), 171–177 (2010)
   PubMedGoogle Scholar
• Kho P, Karunanantham J, Leung M, Lim E. Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact. Cardiovasc. Thorac. Surg. 12(5), 724–727 (2011)
   PubMedGoogle Scholar
• Tacconi F, Pompeo E, Fabbi E, Mineo TC. Awake video-assisted pleural decortication for empyema thoracis. Eur. J. Cardiothor. Surg. 37(3), 594–601 (2010)
   PubMed Web of Science ®Google Scholar
• Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38(3), 316–321 (1996)
   PubMed Web of Science ®Google Scholar
• Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind. Health. 45(3), 379–387 (2007)
   PubMedGoogle Scholar
• Pass HI, Carbone M. Current status of screening for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg. 21(2), 97–104 (2009)
   PubMedGoogle Scholar
• Pass HI, Levin SM, Harbut MR et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N. Med. 367(15), 1417–1427 (2012)
   PubMed Web of Science ®Google Scholar
• Ostroff RM, Mehan MR, Stewart A et al. Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS ONE 7(10), e46091 (2012)
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Astoul P, Baas P et al. European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur. Respir. J. 35(3), 479–495 (2010)
   PubMed Web of Science ®Google Scholar
• Lee C, Bayman N, Swindell R, Faivre-Finn C. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer 66(2), 150–156 (2009)
   PubMedGoogle Scholar
• Van Schil PE, Baas P, Gaafar R et al. European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur. Respir. J. 36(6), 1362–1369 (2010)
   PubMed Web of Science ®Google Scholar
• Finn RS, Brims FJ, Gandhi A et al. Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients. Chest 142(5), 1267–1273 (2012)
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Jaklitsch MT, Bueno R et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J. Thorac. Cardiovasc. Surg. 128(1), 138–146 (2004)
   PubMed Web of Science ®Google Scholar
• Treasure T, Lang-Lazdunski L, Waller D et al. MARS trialists. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 12(8), 763–772 (2011)
   PubMed Web of Science ®Google Scholar
• Flores RM, Pass HI, Seshan VE et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J. Thorac. Cardiovasc. Surg. 135(3), 620–626 (2008)
   PubMed Web of Science ®Google Scholar
• Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 71(1), 75–81 (2011)
   PubMed Web of Science ®Google Scholar
• Nakas A, von Meyenfeldt E, Lau K, Muller S, Waller D. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur. J. Cardiothorac. Surg. 41(5), 1031–1036 (2012)
   PubMed Web of Science ®Google Scholar
• Patel PR, Yoo S, Broadwater G et al. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 83(1), 362–368 (2012)
   PubMed Web of Science ®Google Scholar
• Rosenzweig KE, Zauderer MG, Laser B et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 83(4), 1278–1283 (2012)
   PubMed Web of Science ®Google Scholar
• Minatel E, Trovo M, Polesel J et al. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J. Thorac. Oncol. 7(12), 1862–1866 (2012)
   PubMed Web of Science ®Google Scholar
• Price A. What is the role of radiotherapy in malignant pleural mesothelioma? Oncologist 16(3), 359–365 (2011)
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 21(14), 2636–2644 (2003)
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Gaafar R, Manegold C et al. European Organisation for Research and Treatment of Cancer Lung Cancer Group; National Cancer Institute of Canada. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J. Clin. Oncol. 23(28), 6881–6889 (2005)
   PubMed Web of Science ®Google Scholar
• Buikhuisen WA, Burgers JA, Vincent AD et al. Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study. Lancet Oncol. 14(6), 543–551 (2013)
   PubMed Web of Science ®Google Scholar
• Kindler HL, Karrison TG, Gandara DR et al. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J. Clin. Oncol. 30(20), 2509–2515 (2012)
   PubMed Web of Science ®Google Scholar
• Muers MF, Stephens RJ, Fisher P et al. MS01 Trial Management Group. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 371(9625), 1685–1694 (2008)
   PubMed Web of Science ®Google Scholar
• Haas AR, Sterman DH. Novel intrapleural therapies for malignant diseases. Respiration 83(4), 277–292 (2012)
   PubMed Web of Science ®Google Scholar
• Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 31(2), 85–97 (1987)
   PubMed Web of Science ®Google Scholar
• Astoul P. Malignant mesothelioma. In: Textbook of Pleural Diseases (2nd edition). Light RW, Lee YCG ( Ed.). Hodder-Arnold, UK, 435–444 (2008)
   Google Scholar
• American Thoracic Society. Management of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 162(5), 1987–2001 (2000)
   PubMed Web of Science ®Google Scholar
• Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65 (Suppl. 2), ii32–ii40 (2010)
   PubMed Web of Science ®Google Scholar
• Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 33(4), 916–922 (1974)
   PubMedGoogle Scholar
• Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst. Rev. (1)CD002916 (2004)
   PubMedGoogle Scholar
• Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 49(1), 23–25 (1994)
   PubMed Web of Science ®Google Scholar
• Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 54(1), 51–55 (2006)
   PubMed Web of Science ®Google Scholar
• Davies HE, Mishra EK, Kahan BC et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 307(22), 2383–2389 (2012)
   PubMed Web of Science ®Google Scholar
• Warren WH, Kalimi R, Khodadadian LM, Kim AW. Management of malignant pleural effusions using the Pleur(x) catheter. Ann. Thorac. Surg. 85(3), 1049–1055 (2008)
   PubMed Web of Science ®Google Scholar
• Dresler CM, Olak J, Herndon JE 2nd et al. Cooperative Groups Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cooperative Oncology Group; Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127(3), 909–915 (2005)
   PubMed Web of Science ®Google Scholar
• Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. Fibrin turnover in lung inflammation and neoplasia. Am. J. Respir. Crit. Care Med. 163(2), 578–584 (2001)
   PubMedGoogle Scholar
• Davies CW, Traill ZC, Gleeson FV, Davies RJ. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 115(3), 729–733 (1999)
   PubMedGoogle Scholar
• Melton LJ 3rd, Hepper NG, Offord KP. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am. Rev. Respir. Dis. 120(6), 1379–1382 (1979)
   PubMedGoogle Scholar
• Bense L, Eklund G, Wiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 92(6), 1009–1012 (1987)
   PubMed Web of Science ®Google Scholar
• Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax 55(8), 666–671 (2000)
   PubMed Web of Science ®Google Scholar
• Tanaka F, Itoh M, Esaki H, Isobe J, Ueno Y, Inoue R. Secondary spontaneous pneumothorax. Ann. Thorac. Surg. 55(2), 372–376 (1993)
   PubMed Web of Science ®Google Scholar
• Shields TW, Oilschlager GA. Spontaneous pneumothorax in patients 40 years of age and older. Ann. Thorac. Surg. 2(3) 377–383 (1966)
   PubMedGoogle Scholar
• Bense L, Lewander R, Eklund G, Hedenstierna G, Wiman LG. Nonsmoking, non-alpha 1-antitrypsin deficiency-induced emphysema in nonsmokers with healed spontaneous pneumothorax, identified by computed tomography of the lungs. Chest 103(2), 433–438 (1993)
   PubMedGoogle Scholar
• Amjadi K, Alvarez GG, Vanderhelst E, Velkeniers B, Lam M, Noppen M. The prevalence of blebs or bullae among young healthy adults: a thoracoscopic investigation. Chest 132(4), 1140–1145 (2007)
   PubMedGoogle Scholar
• Noppen M, Dekeukeleire T, Hanon S et al. Fluorescein-enhanced autofluorescence thoracoscopy in patients with primary spontaneous pneumothorax and normal subjects. Am. J. Respir. Crit. Care Med. 174(1), 26–30 (2006)
   PubMedGoogle Scholar
• Noppen M, Keukeleire T. Pneumothorax. Respiration 76(2), 121–127 (2008)
   PubMed Web of Science ®Google Scholar
• Smit HJ, Golding RP, Schramel FM, Devillé WL, Manoliu RA, Postmus PE. Lung density measurements in spontaneous pneumothorax demonstrate airtrapping. Chest 125(6), 2083–2090 (2004)
   PubMedGoogle Scholar
• Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur. J. Cardiothorac. Surg. 32(6), 834–838 2007)
   PubMedGoogle Scholar
• Arnold A, Harvey J, MacDuff A; BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65( Suppl. 65), ii18–ii31 (2010)
   PubMedGoogle Scholar
• Ruckley CV, McCormack RJM. The management of spontaneous pneumothorax. Thorax 21(2), 139–144 (1966)
   PubMedGoogle Scholar
• Poole G, Stradling P. Conservative management of spontaneous pneumothorax. Thorax 21(2), 145–149 (1966)
   PubMedGoogle Scholar
• Kelly AM, Loy J, Tsang AY, Graham CA. Estimating the rate of re-expansion of spontaneous pneumothorax by a formula derived from computed tomography volumetry studies. Emerg. Med. J. 23(10) 780–782 (2006)
   PubMedGoogle Scholar
• Noppen M, Alexander P, Driesen P, Slabbynck H, Verstraeten A. Manual aspiration versus chest tube drainage in first episodes of primary spontaneous pneumothorax: a multicentre prospective, randomized pilot study. Am. J. Respir. Crit. Care Med. 165(9), 1240–1244 (2002)
   PubMed Web of Science ®Google Scholar
• Wakai A, O'Sullivan RG, McCabe G. Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults. Cochrane Database Syst. Rev. (1):CD004479 (2007)
   Google Scholar
• Baumann MH, Strange C, Heffner JE et al. AACP Pneumothorax Consensus Group. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 119(2), 590–602 (2001)
   PubMed Web of Science ®Google Scholar
• De Leyn P, Lismonde M, Ninane V et al. Guidelines Belgian Society of Pneumology Guidelines on the management of spontaneous pneumothorax. Acta. Chir. Belg. 105(3), 265–267 (2005)
   PubMed Web of Science ®Google Scholar
• Kelly AM, Druda D. Comparison of size classification of primary spontaneous pneumothorax by three international guidelines: a case for international consensus? Respir. Med. 102(12), 1830–1832 (2008)
   PubMedGoogle Scholar
• Baumann MH, Strange C. The clinician's perspective on pneumothorax management. Chest 112(3), 822–828 (1997)
   PubMedGoogle Scholar
• Chen W, Lee JC, Cheng WE et al. Pigtail catheters vs large-bore chest tubes for management of secondary spontaneous pneumothoraces in adults. Am. J. Emerg. Med. 24(7), 795–800 (2006)
   PubMedGoogle Scholar
• Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF. Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothorax. Arch. Surg. 126(6), 764–766 (1991)
   PubMedGoogle Scholar
• Chee CB, Abisheganaden J, Yeo JK et al. Persistent air-leak in spontaneous pneumothorax – clinical course and outcome. Respir. Med. 92(5), 757–761 (1998)
   PubMed Web of Science ®Google Scholar
• Mercier C, Page A, Verdant A, Cossette R, Dontigny L, Pelletier LC. Outpatient management of intercostal tube drainage in spontaneous pneumothorax. Ann. Thorac. Surg. 22(2), 163–165 (1976)
   PubMedGoogle Scholar
• Brims FJ, Maskell NA. Ambulatory treatment in the management of pneumothorax: a systematic review of the literature. Thorax 68(7), 664–669 (2013)
   PubMed Web of Science ®Google Scholar
• Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106(4), 1215–1222 (1994)
   PubMedGoogle Scholar
• Tschopp JM, Boutin C, Astoul P et al.; ESMEVAT team (European Study on Medical Video-Assisted Thoracoscopy). Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study. Eur. Respir. J. 20(4), 1003–1009 (2002)
   PubMedGoogle Scholar
• Rahman NM, Ali NJ, Brown G et al.; British Thoracic Society Pleural Disease Guideline Group. Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010. Thorax 65 (Suppl. 2), ii54–ii60 (2010)
   PubMed Web of Science ®Google Scholar
• Bille A, Barker A, Maratos EC, Edmonds L, Lim E. Surgical access rather than method of pleurodesis (pleurectomy or pleural abrasion) influences recurrence rates for pneumothorax surgery: systematic review and meta-analysis. Gen. Thorac. Cardiovasc. Surg. 60(6), 321–325 (2012)
   PubMedGoogle Scholar
• Mathur R, Cullen J, Kinnear WJ, Johnston ID. Time course of resolution of persistent air leak in spontaneous pneumothorax. Respir. Med. 89(2), 129–132 (1995)
   PubMed Web of Science ®Google Scholar
• Horio H, Nomori H, Kobayashi R, Naruke T, Suemasu K. Impact of additional pleurodesis in video-assisted thoracoscopic bullectomy for primary spontaneous pneumothorax. Surg. Endosc. 16(4), 630–634 (2002).
   PubMedGoogle Scholar
• Havelock T, Teoh R, Laws D, Gleeson F; British Thoracic Society Pleural Disease Guideline Group. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax 65 (Suppl. 2), ii61–ii76 (2010)
   PubMed Web of Science ®Google Scholar